Stroke Treatment With PAR-1 Agents to Decrease Hemorrhagic Transformation

Ischemic stroke is the most widespread cause of disability and a leading cause of death in developed countries. To date, the most potent approved treatment for acute stroke is recanalization therapy with thrombolytic drugs such as tissue plasminogen activator (rt-PA or tPA) or endovascular mechanica...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Neurol
Main Authors: Lyden, Patrick D., Pryor, Kent E., Minigh, Jennifer, Davis, Thomas P., Griffin, John H., Levy, Howard, Zlokovic, Berislav V.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2021
Assuntos:
Neurology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8005555/
https://ncbi.nlm.nih.gov/pubmed/33790846
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2021.593582
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados